603233: DaShenLin Pharmaceutical Group Co., Ltd. - Summary | Jitta

DaShenLin Pharmaceutical Group Co., Ltd.

CHN:603233

Price
CN¥15.87
Loss Chance
41.8%
6.89JITTA SCORE
42.98%Under Jitta Line
Jitta Ranking
54 / 5,271
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (59)
Recent Business Performance (93)
Financial Strength (88)
Return to Shareholders (68)
Competitive Advantage (73)
Jitta Signs
Revenue and EarningConsistent
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Cash Conversion CycleLess than 30 days
Key Stats
Jitta Score
Jitta Line
6.89
42.98%
3.94
> 1,000%
Drug Retail
5.56
> 1,000%
2.83
> 1,000%
4.46
100.00%
COMPANY DESCRIPTION
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.